Showing 2,141 - 2,160 results of 17,627 for search '"The Progressive"', query time: 0.09s Refine Results
  1. 2141
  2. 2142

    Stress-Strength Reliability of Two-Parameter Exponential Distribution Based on Progres- sively Type-II Censored Data by Sajad Rostamian

    Published 2024-12-01
    Subjects: “…Generalized pivotal quantity, Bayesian estimation, Gibbs sampling, Progressively type-ΙΙ censoring, Two-parameter exponential distribution…”
    Get full text
    Article
  3. 2143
  4. 2144

    基于脑机接口的脑血管病后肢体运动功能康复研究进展 Research Progress of Limb Motor Function Rehabilitation after Cerebrovascular Diseases Based on Brain-Computer Interface by 桑振华1,2,薛司洋2,3,魏宸铭3,武剑3,4 (SANG Zhenhua1,2, XUE Siyang2,3, WEI Chenming3, WU Jian3,4 )

    Published 2025-01-01
    “…This paper reviews the mechanisms of BCI technology in treating motor disorders after cerebrovascular diseases and the progress of electroencephalography-based BCI application in the rehabilitation of upper and lower limb motor disorders. …”
    Get full text
    Article
  5. 2145

    Circulating sCD138 and Some Angiogenesis-Involved Cytokines Help to Anticipate the Disease Progression of Early-Stage <mml:math><mml:mi>B</mml:mi></mml:math>-Cell Chronic Lymphocytic Leukemia

    Published 2006-01-01
    “…In patients with sCD138 level or endostatin level below the median value the lymphocyte count was higher than in patients with serum level of those cytokines above the median value. In patients with progressive disease bFGF level was significantly higher and sCD138 level significantly lower than in patients with stable one. …”
    Get full text
    Article
  6. 2146
  7. 2147

    Rationale and design of the multicenter, national, randomized, open labeled phase III trial: allogeneic stem cell transplantation as a potential curative treatment for patients with relapsed or progressed multiple myeloma (AlloRelapseMM Study) by Annemarie Glöckner, Stefan Schönland, Hermann Einsele, Nicolaus Kröger

    Published 2025-01-01
    “…Abstract Background Even though major improvements have been made in the treatment of myeloma, the majority of patients eventually relapse or progress. Patients with multiple myeloma who relapse after initial high-dose chemotherapy with autologous stem cells have a median progression free survival up to 2–3 years, depending on risk factors such as previous remission duration. …”
    Get full text
    Article
  8. 2148
  9. 2149
  10. 2150

    Research progress of integrated traditional Chinese and western medicine nursing in non-operative treatment of intestinal obstruction and abdominal pain (非手术治疗肠梗阻腹痛的中西医结合护理进展) by HOU Pengxiao (候朋晓), LI Ying (李影), SUN Lei (孙磊), REN Yaxing (任亚星), HAN Jianping (韩建萍)

    Published 2023-04-01
    “…This paper expounds the progress of non-surgical nursing of patients with intestinal obstruction by integrated traditional Chinese and Western medicine, and summarizes the advantages of integrated traditional Chinese and Western medicine nursing intervention. …”
    Get full text
    Article
  11. 2151

    The Role of Indoxyl Sulfate in Exacerbating Colorectal Cancer During Chronic Kidney Disease Progression: Insights into the Akt/β-Catenin/c-Myc and AhR/c-Myc Pathways in HCT-116 Colorectal Cancer Cells by Yu Ichisaka, Chihiro Takei, Kazuma Naito, Manami Higa, Shozo Yano, Toshimitsu Niwa, Hidehisa Shimizu

    Published 2025-01-01
    “…Our previous study demonstrated that indoxyl sulfate, a uremic toxin whose concentration increases with CKD progression, exacerbates CRC through activation of the AhR and Akt pathways. …”
    Get full text
    Article
  12. 2152

    Isolated Central Nervous System Infiltrated and Progressed to Acute Myeloid Leukemia from Chronic Myeloid Leukemia with e1a3 BCR-ABL1 Transcript: A Rare Case Report and Literature Review by Qiang X, Wen Q, Li J, Chen S, Tao T, Zhang H, Wang P, Peng X, Feng Y, Zhang X

    Published 2025-01-01
    “…Subsequent bone marrow analysis and flow cytometry detection of cerebrospinal fluid indicated that the patient had entered the blast phase, progressing to acute myeloid leukemia (AML). Treatment was switched to the third-generation TKI olverembatinib, combined with chemotherapy, followed by allogeneic hematopoietic stem cell transplantation. …”
    Get full text
    Article
  13. 2153
  14. 2154
  15. 2155
  16. 2156
  17. 2157
  18. 2158
  19. 2159
  20. 2160